
Please try another search
BioSenic S.A., a biotechnology company, develops cell therapy products and treatments for autoimmune and inflammatory diseases in Belgium and France. The company’s technologies include arsenic trioxide (ATO) and oral arsenic trioxide (OATO) platforms. It also provides medicinal products, including ArsciMed, an intravenous drug to treat autoimmune diseases. In addition, the company develops ArsciCor, an oral medication in Phase III clinical trial and for the treatment for chronic graft-versus-host disease; JTA-004, an intra-articular injectable in Phase III clinical trial to treat osteoarthritic knee pain; ALLOB, an allogeneic differentiated osteoblast product in Phase IIb clinical trial for patients with difficult tibial fractures and lumbar spinal fusion; and ARSCICOP, an oral medication in Phase IIa trial for the treatment of systemic lupus erythematosus, as well as in preclinical trial to treat systemic sclerosis. BioSenic S.A. is based in Mont-Saint-Guibert, Belgium.
Name | Age | Since | Title |
---|---|---|---|
Carlo Chizzolini | - | - | Member of Scientific Advisory Board |
Alain Fischer | - | - | Member of Scientific Advisory Board |
Jean-François Bach | - | - | Member of Scientific Advisory Board |
Jean-Luc Vandebroek | 53 | 2022 | Non-Executive Director |
Jules Hoffmann | - | - | Chairman of Scientific Advisory Board |
Bernard Malissen | - | - | Member of Scientific Advisory Board |
Frédéric Houssiau | - | - | Member of Scientific Advisory Board |
Jean Stephenne | - | 2022 | Independent Director |
Revital Rattenbach | 48 | 2022 | Independent Director |
Jean-François Rax | - | 2022 | Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review